The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
M SilsbyR Y Tweedie-CullenC R MurrayG M HallidayJ R HodgesJames R BurrellPublished in: European journal of neurology (2017)
The M/P ratio was disproportionately reduced in PSP, suggesting its potential as a clinical marker of the PSP syndrome. Larger studies of pathologically confirmed cases are needed to establish the M/P ratio as a biomarker of PSP pathology.
Keyphrases